COVID-19 pregnancy medicine registry for expecting or recent mothers
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study is a registry that collects information about COVID-19 during pregnancy, including what treatments were used and pregnancy outcomes. It may help doctors better understand the safety and effects of COVID-19 medicines in pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant now or became pregnant within the last 30 days
- You are 18 years or older
- You had COVID-19 during your pregnancy (from mild to severe)
- You either took a COVID-19 medicine during pregnancy, or you were hospitalized but did not receive COVID-19 medicines specifically for treatment
- You live in a country where an ethics board gave approval (or approval is not needed there)
- You agree to join and complete the starting paperwork about COVID-19 medicines during your pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies COVID risk to predict who is more likely to need hospital care and to better understand how COVID spreads. It may help future patients by improving risk assessment using test results and risk scores.
This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.
This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.
This study follows pregnant women and their babies to learn more about COVID-19 and how it affects them. By taking part, you help researchers understand the virus and improve care for mothers and children.
This study follows pregnant women in Nagpur to understand how influenza and COVID-19 affect them and their babies. Participants will be contacted twice a week for symptom checks and may provide blood samples at key points during pregnancy.
This study helps track how psychiatric (mental health) medicines affect pregnancy outcomes by collecting phone interviews during pregnancy. If you are pregnant and take (or have taken) mental health medication, you may help doctors understand risks and benefits better.
Hear when a new Covid19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.